Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13578488 | 0.85 | — | — | |
| SCHEMBL8967194 | 0.83 | — | — | |
| SCHEMBL8967283 | 0.79 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL9915232 | 0.78 | — | — | |
| SCHEMBL19202298 | 0.77 | — | — | |
| SCHEMBL11030115 | 0.77 | LMNA (0.43) | LMNA | |
| SCHEMBL7882500 | 0.75 | CA1 (0.31) | CA1 | |
| SCHEMBL11959619 | 0.75 | — | — | |
| SCHEMBL21550878 | 0.75 | — | — | |
| SCHEMBL6008872 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 641 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119080614-A | Production process of difluoroethyl acetate | 南通宝凯药业有限公司 | 2024-12-06 | — | — | CN | claimed |
| EP-4368621-A1 | METHOD FOR PREPARING NITROGEN-CONTAINING POLYCYCLIC FUSED RING COMPOUND, AND INTERMEDIATE AND USE OF COMPOUND | Applied Pharmaceutical Science, Inc. (CN) | 2024-05-15 | — | — | EP | claimed |
| CN-117561259-A | Preparation method of nitrogen-containing polycyclic condensed ring compound, intermediate and application thereof | 北京志健金瑞生物医药科技有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-113851761-B | High reversible zinc-air battery | 中国科学院青岛生物能源与过程研究所 | 2023-06-30 | — | — | CN | claimed |
| CN-115594678-A | Preparation method of nitrogen-containing polycyclic fused ring compound, intermediate and application thereof | 北京志健金瑞生物医药科技有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| WO-2023280073-A1 | METHOD FOR PREPARING NITROGEN-CONTAINING POLYCYCLIC FUSED RING COMPOUND, AND INTERMEDIATE AND USE OF COMPOUND | 北京志健金瑞生物医药科技有限公司 | 2023-01-12 | — | — | WO | claimed |
| CN-113851761-A | High reversible zinc-air battery | 中国科学院青岛生物能源与过程研究所 | 2021-12-28 | — | — | CN | claimed |
| CN-112584866-A | Application of sulfoxide compound in preventing radioactive oral mucositis and related radiotherapy complications | 北京蔚蓝之源医药科技有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-111465633-A | Aqueous composition comprising conductive polymer and use thereof | 艾尼股份公司 | 2020-07-28 | — | — | CN | claimed |
| CN-110731954-A | Application of sulfoxide compound in preventing complications of thoracic and abdominal tumor radiotherapy | 北京蔚蓝之源医药科技有限公司 | 2020-01-31 | — | — | CN | claimed |
| CN-103687831-B | Process for preparing 2, 2-difluoroethanol | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-11-25 | — | — | CN | claimed |
| EP-2734493-B1 | PROCESS FOR PREPARING 2,2-DIFLUOROETHANOL | BAYER IP GMBH (DE) | 2015-08-19 | — | — | EP | claimed |
| US-8975448-B2 | Process for preparing 2,2-difluoroethanol | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-03-10 | — | — | US | claimed |
| US-20140243561-A1 | PROCESS FOR PREPARING 2,2-DIFLUOROETHANOL | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-08-28 | — | — | US | claimed |
| EP-2734493-A1 | PROCESS FOR PREPARING 2,2-DIFLUOROETHANOL | Bayer Intellectual Property GmbH (DE) | 2014-05-28 | — | — | EP | claimed |
| CN-103687831-A | Process for preparing 2, 2-difluoroethanol | BAYER IP GMBH | 2014-03-26 | — | — | CN | claimed |
| WO-2013010985-A1 | PROCESS FOR PREPARING 2,2-DIFLUOROETHANOL | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-01-24 | — | — | WO | claimed |
| CN-1058399-A | New piperidine ether and thioether as cholesteral biosynthesis inhibitor | MERRELL DOW PHARMA (US) | 1992-02-05 | — | — | CN | claimed |
| US-3966727-A | Manufacture of phthalo-bis-guanamines | BASF AKTIENGESELLSCHAFT (DT) | 1976-06-29 | — | — | US | claimed |
| US-3941717-A | Process for the production of a catalyst comprising a novel metal on activated carbon | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1976-03-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140243561-A1 | PROCESS FOR PREPARING 2,2-DIFLUOROETHANOL | FUCA2, ADH1A, ADH1C | CA1 57/4885ALDH1A1 91/4885LMNA 3594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.